Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News TREATWolfram clinical trial to unlock a potential treatment for a rare disease Birmingham is making a real-world impact on rare diseases, with a comprehensive multi-facility network for research helping to find new treatments for patients like those with Wolfram syndrome.
News Stopping the awakening of sleeping Acute Myeloid Leukaemia stem cells to prevent disease relapse
News Cancer Research UK Clinical Trials Unit: Celebrating 40 Years of Funding From Cancer Research UK
25 July 2023 ICGS has three new Professors The Institute of Cancer and Genomic Sciences has three new Professors: Eva Petermann, Aga Gambus and Simon Bach.
25 July 2023 Vaccine rollout cut Covid deaths for cancer patients by 84% New two year UK-wide study finds Covid-19 risk for cancer patients still higher than general population, but fell following availability of vaccinations in 2021
06 July 2023 Many clinically at-risk patients mounted low or no immune response to Covid vaccines OCTAVE study reveals real-world vaccine response in patients with impaired immune systems
21 June 2023 Genetic mutations blunt immune defences in leukaemia-linked rare bone marrow disorder Zebrafish used to identify bone marrow failures in GATA2 deficiency that result in defective DNA repair and marrow failure
09 June 2023 World leading cancer trials in Birmingham get £10 million boost University of Birmingham set for renewal of pioneering Cancer Research Clinical Trials Unit which delivers more than 100 national and international trials
17 May 2023 Brain cell death in rare disease Wolfram syndrome linked to mitochondrial defects The Sarkar and Barrett labs have defined the molecular basis of neurodegeneration in Wolfram Syndrome patients carrying the WFS1 gene mutation.